Speaker illustration

Doctor Nicholay Teodorovich

Kaplan Medical Center, Rehovot (Israel)

Member of:

European Society of Cardiology
European Heart Rythm Association

Mortality and appropriate therapies in ischaemic ICD recipients according to the electrophysiological study

Event: ESC Congress 2023

Topic: Implantable Cardioverter-Defibrillator (ICD)

Session: Recent advances in implantable cardioverter defibrillator therapy and remote monitoring

Thumbnail

Renal insufficiency mitigates the protective effects of elevated anti endothelial cell antibodies on survival in patients undergoing coronary angiography

Event: ESC Congress 2019

Topic: Biomarkers

Session: Vascular disease

Thumbnail

The additive effect of diastolic dysfunction and renal insufficiency on mortality in patients undergoing coronary angiography

Event: ESC Congress 2019

Topic: Systolic and Diastolic Function

Session: New approaches to diastolic function assessment

Thumbnail

Cryoballoon pulmonary vein isolation is effective in both paroxysmal and persistent atrial fibrillation

Event: EHRA 2019

Topic: Rhythm Control, Catheter Ablation

Session: Atrial Fibrillation - Treatment

Thumbnail

Diastolic dysfunction is an independent predictor of mortality in patients undergoing coronary angiography

Event: ESC Congress 2018

Topic: Systolic and Diastolic Function

Session: Left ventricular mechanics

Thumbnail

Elevated antiendothelial cell antibodies are associated with higher likelihood of normal coronary angiograms.

Event: ESC Congress 2017

Topic: Inflammation and microcirculation

Session: Coronary artery disease: from bench to bedside

Thumbnail

Atrial fibrillation is an Independent predictor of mortality in patients undergoing coronary angiography.

Event: EHRA EUROPACE - CARDIOSTIM 2017

Topic: Clinical and epidemiological aspects (Atrial Fibrillation)

Session: Atrial Fibrillation - Clinical and epidemiological aspects

Thumbnail

CHA2DS2VASC score is predictive of mortality in patients undergoing coronary angiography

Event: ESC Congress 2016

Topic: Risk scores

Session: Outcomes in atrial fibrillation

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb